SPONSOR
Changchun GeneScience Pharmaceutical Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1, Phase 3
Changchun GeneScience Pharmaceutical Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Endometriosis-related Pain, Advanced Solid Tumors, Hyperprolactinemia.
The trial portfolio spans Phase 2, Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Changchun GeneScience Pharmaceutical Co., Ltd.
How many clinical trials has Changchun GeneScience Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Changchun GeneScience Pharmaceutical Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Endometriosis-related Pain, Advanced Solid Tumors, Hyperprolactinemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Changchun GeneScience Pharmaceutical Co., Ltd. research focus on?
Changchun GeneScience Pharmaceutical Co., Ltd. clinical trials span Endometriosis-related Pain, Advanced Solid Tumors, Hyperprolactinemia. The research pipeline includes Phase 2, Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Changchun GeneScience Pharmaceutical Co., Ltd. clinical trial?
To participate in a Changchun GeneScience Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Changchun GeneScience Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Changchun GeneScience Pharmaceutical Co., Ltd.
NCT06963177 Phase 2
Recruiting
A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
Endometriosis-related Pain
NCT07230977 Phase 1
Recruiting
GenSci139 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
NCT07124221 Phase 3
Recruiting
A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets
Hyperprolactinemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology